Skip to main content
. 2021 May 17;2021:6663646. doi: 10.1155/2021/6663646

Figure 5.

Figure 5

Sensitivity analysis: (a) for the strength of association between anxiety and vitiligo; (b) for the female predominance (OR) of anxiety in patients with vitiligo; (c) for the female predominance (SMD) of anxiety in patients with vitiligo; (d) for the pooled prevalence of anxiety in patients with vitiligo.